Systemic changes in serum-induced T cell transcriptional analysis and inflammatory profiles in patients who undergo islet and pancreas transplantation

This abstract has open access
Abstract Summary

Cell replacement therapy in type 1 diabetes (T1D) can be achieved by the transplantation of whole pancreas or pancreatic islets. Despite receiving conditioning regimen and immunosuppressive maintenance therapy, some patients show T cell-mediated allograft rejection and/or recurrence of autoimmunity post-transplantation. Here, we aimed to determine how the humoral environment post-transplant affects T cell activation. Inflammatory profiles were determined in sera from patients receiving either islet, pancreas, pancreas/kidney or auto-transplantation and healthy controls (HC) and T1D controls. The effect of this serum environment on T cell activation was examined by serum-induced transcriptional analysis: purified Treg and CD8+ memory T cells from healthy human donors were used as responder cells and exposed to low anti-CD3/CD28 bead stimulation in the presence of 30% of patient sera. Harvested RNA was subjected to RNA sequencing. Hierarchical cluster analysis of sera cytokines/chemokine profiles defined five clusters whose distribution varied substantially between serum-subject groups. T1D patients had more inflammatory profiles as compared to HC, who were largely low inflammatory, and patients post-transplant who had an IL-7 profile. There were marked differences between the serum-subject groups in the gene expression profiles of Treg and CD8+ T cells after activation in the presence of patient serum. An increased activation of TCR- and downstream signaling pathways was observed in the presence of sera from patients with long-standing T1D as compared to HC. Despite a high IL-7 feature in the cytokine/chemokine profile, JAK/STAT and downstream pathways of TCR-signaling were downregulated post-pancreas transplant. The findings suggest that patients with long-standing T1D have an enhanced ability to activate T cells and that serum-induced transcriptional analyses may be helpful in the management of patients post-transplant.

Submission ID :
IDS54103
Submission Type
Abstract Topics
DFG-Center for Regenerative Therapies Dresden Cluster of Excellence / TU Dresden, Dresden, Germany
Institute of Diabetes Research, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich-Neuherberg, Germany
CRTD-DFG Center for Regenerative Therapies Dresden, Carl Gustav Carus Faculty of Medicine, Technische Universität Dresden, Dresden, Germany
University Hospital Carl Gustav Carus, Dept. of Medicine III, TU Dresden, Dresden, Germany
CRTD Center for Regenerative Therapies Dresden

Abstracts With Same Type

Submission ID
Submission Title
Submission Topic
Submission Type
Primary Author
1 visits

KEY DATES

Event dates:
Thursday 25 October - Monday 29 October 2018

Abstract submission deadline:
Monday 14 May 2018

Abstract notification:
July 2018

Early registration deadline:
Monday 3 September 2018

Registration deadline:
Monday 15 October 2018

Contact
British Society for Immunology
+44 (0)20 3019 5901
congress@immunology.org